| |
| |
|
| Insider
Information: |
Barabe Timothy C |
| Relationship: |
Director |
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
663,514 |
|
|
Indirect Shares
|
7,120 |
|
|
| Direct
Value |
$1,614,265 |
|
|
|
Indirect Value
|
$142,400 |
|
|
| Total
Shares |
670,634 |
|
|
| Total
Value |
$1,756,665 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
5
|
|
Stock
price went up :
|
3
|
5
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
5.0
|
| Percentage
Gain/Loss : |
 51.6%
|
100.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2005-03-04 |
7,120 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Chief Financial Officer |
2010-02-22 |
49,570 |
2007-06-27 |
0 |
Premium* |
|
|
Affymetrix Inc |
AFFX |
Chief Financial Officer |
2013-03-18 |
166,378 |
|
0 |
Premium* |
|
|
Acer Therapeutics Inc |
ACER |
Director |
2016-11-18 |
12,910 |
2014-03-19 |
0 |
Premium* |
|
|
Veeva Systems Inc |
VEEV |
Director |
2021-06-22 |
6,643 |
2015-12-09 |
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
Director |
2024-01-02 |
428,013 |
2017-03-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
252 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQL |
Arqule Inc |
Director |
– • – |
2016-03-22 |
4 |
A |
$1.73 |
$1,199 |
D/D |
693 |
112,928 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-04-26 |
4 |
A |
$1.67 |
$750 |
D/D |
449 |
113,780 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-05-18 |
4 |
A |
$1.59 |
$5,999 |
D/D |
3,773 |
117,553 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-05-24 |
4 |
A |
$1.68 |
$1,200 |
D/D |
714 |
118,267 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-07-18 |
4 |
A |
$1.63 |
$1,200 |
D/D |
736 |
119,003 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-07-27 |
4 |
A |
$1.63 |
$750 |
D/D |
460 |
119,463 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-08-18 |
4 |
A |
$1.53 |
$5,999 |
D/D |
3,921 |
123,384 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-09-20 |
4 |
A |
$1.60 |
$2,400 |
D/D |
1,500 |
124,884 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-10-25 |
4 |
A |
$1.41 |
$749 |
D/D |
531 |
125,415 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-11-15 |
4 |
A |
$1.38 |
$1,950 |
D/D |
1,413 |
126,828 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-11-18 |
4 |
A |
$1.40 |
$5,999 |
D/D |
4,285 |
131,113 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2017-01-17 |
4 |
A |
$1.53 |
$1,200 |
D/D |
784 |
131,897 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2017-02-18 |
4 |
A |
$1.20 |
$6,000 |
D/D |
5,000 |
136,897 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2019-04-04 |
4 |
OE |
$3.87 |
$38,700 |
D/D |
10,000 |
146,897 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2020-01-16 |
4 |
D |
$20.00 |
$2,937,940 |
D/D |
(146,897) |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2007-06-27 |
4 |
B |
$9.00 |
$24,300 |
D/D |
2,700 |
2,700 |
2.74 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2007-06-28 |
4 |
B |
$9.10 |
$66,430 |
D/D |
7,300 |
10,000 |
2.74 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2007-07-11 |
4 |
B |
$7.59 |
$15,126 |
D/D |
1,993 |
11,993 |
2.74 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2008-03-07 |
4 |
B |
$5.14 |
$51,400 |
D/D |
10,000 |
21,993 |
2.74 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2008-07-01 |
4 |
B |
$4.49 |
$10,242 |
D/D |
2,281 |
24,274 |
2.74 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2008-11-13 |
4 |
B |
$2.00 |
$19,978 |
D/D |
10,000 |
34,274 |
2.74 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2008-11-14 |
4 |
B |
$1.99 |
$19,900 |
D/D |
10,000 |
44,274 |
2.74 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2009-06-30 |
4 |
B |
$1.80 |
$1,800 |
D/D |
1,000 |
45,274 |
2.66 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2009-11-20 |
4 |
OE |
$10.11 |
$299,994 |
D/D |
29,673 |
39,674 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2010-02-03 |
4 |
AS |
$27.92 |
$639,481 |
D/D |
(22,907) |
45,096 |
0 |
- |
|
252 Records found
|
|
Page 8 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
